Cladis Investment Advisory, LLC Bristol Myers Squibb CO Transaction History

Cladis Investment Advisory, LLC

$144 Billion
Q3 2024

A detailed history of Cladis Investment Advisory, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 29,507 shares of BMY stock, worth $1.73 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

29,507

Previous 29,536 0.1%

Holding current value

$1.73 Million

Previous $1.23 Billion 24.46%

% of portfolio

1.06%

Previous 0.89%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $1,150 - $1,500	-29 Reduced 0.1%	29,507 $1.53 Billion
Q2 2024 Oct 09, 2024	BUY	$40.25 - $52.99 $15,415 - $20,295	383 Added 1.31%	29,536 $1.23 Billion
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $15,415 - $20,295	383 Added 1.46%	26,536 $1.1 Million
Q1 2024 Oct 09, 2024	BUY	$47.98 - $54.4 $125,563 - $142,364	2,617 Added 9.86%	29,153 $1.58 Billion
Q1 2024 May 13, 2024	BUY	$47.98 - $54.4 $16,793 - $19,040	350 Added 1.36%	26,153 $1.42 Million
Q4 2023 Oct 09, 2024	BUY	$48.48 - $57.85 $9,696 - $11,570	200 Added 0.7%	28,803 $1.48 Billion
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $9,696 - $11,570	200 Added 0.78%	25,803 $1.32 Million
Q3 2023 Oct 09, 2024	BUY	$57.89 - $64.73 $119,658 - $133,796	2,067 Added 7.79%	28,603 $1.66 Billion
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $28,945 - $32,365	-500 Reduced 1.92%	25,603 $1.49 Million
Q2 2023 Oct 09, 2024	BUY	$63.71 - $70.74 $5,479 - $6,083	86 Added 0.3%	29,103 $1.86 Billion
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $5,479 - $6,083	86 Added 0.33%	26,103 $1.67 Million
Q1 2023 Oct 09, 2024	BUY	$65.71 - $74.53 $163,026 - $184,908	2,481 Added 9.35%	29,017 $2.01 Billion
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $21,881 - $24,818	-333 Reduced 1.26%	26,017 $1.8 Million
Q4 2022 Oct 09, 2024	SELL	$68.48 - $81.09 $83,408 - $98,767	-1,218 Reduced 3.98%	29,350 $2.11 Billion
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $14,928 - $17,677	-218 Reduced 0.82%	26,350 $1.9 Million
Q3 2022 Oct 09, 2024	BUY	$0.13 - $76.84 $524 - $309,818	4,032 Added 15.19%	30,568 $2.17 Billion
Q3 2022 Nov 17, 2022	SELL	$0.13 - $76.84 $104 - $61,472	-800 Reduced 2.92%	26,568 $1.89 Million
Q2 2022 Oct 09, 2024	BUY	$72.62 - $79.98 $350,899 - $386,463	4,832 Added 18.21%	31,368 $2.42 Billion
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $36,310 - $39,990	-500 Reduced 1.79%	27,368 $2.11 Million
Q1 2022 Oct 08, 2024	SELL	$61.48 - $73.72 $49,184 - $58,976	-800 Reduced 2.45%	31,868 $2.33 Billion
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $12,296 - $14,744	200 Added 0.72%	27,868 $2.04 Million
Q4 2021 Oct 08, 2024	BUY	$53.63 - $62.52 $328,859 - $383,372	6,132 Added 23.11%	32,668 $2.04 Billion
Q4 2021 Oct 01, 2024	BUY	$53.63 - $62.52 $328,859 - $383,372	6,132 Added 23.11%	32,668 $1.73 Billion
Q4 2021 May 10, 2022	BUY	$53.63 - $62.52 $1.48 Million - $1.73 Million	27,668 New	27,668 $1.73 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cladis Investment Advisory, LLC with notifications on news.

Account

Cladis Investment Advisory, LLC Bristol Myers Squibb CO Transaction History